{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:22:37Z","timestamp":1790418157684,"version":"4.1.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","liver.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.cld.2015.10.011","type":"journal-article","created":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T08:45:30Z","timestamp":1451292330000},"page":"293-312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":270,"title":["Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children"],"prefix":"10.1016","volume":"20","author":[{"given":"David E.","family":"Kleiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala R.","family":"Makhlouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cld.2015.10.011_bib1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/hep.24376","article-title":"Endpoints and clinical trial design for nonalcoholic steatohepatitis","volume":"54","author":"Sanyal","year":"2011","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2015.10.011_bib2","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/hep.1840360609","article-title":"NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States","volume":"36","author":"Marrero","year":"2002","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.cld.2015.10.011_bib3","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","article-title":"The prevalence of hepatitis C virus infection in the United States, 1999 through 2002","volume":"144","author":"Armstrong","year":"2006","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.cld.2015.10.011_bib4","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2015.10.011_bib5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-0028-1091978","article-title":"The epidemiology of nonalcoholic fatty liver disease: a global perspective","volume":"28","author":"Lazo","year":"2008","journal-title":"Semin Liver Dis"},{"issue":"5","key":"10.1016\/j.cld.2015.10.011_bib6","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.1840120505","article-title":"Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors","volume":"12","author":"Wanless","year":"1990","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2015.10.011_bib7","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2015.10.011_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.MP.0000042420.21088.C7","article-title":"Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease","volume":"16","author":"Brunt","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cld.2015.10.011_bib9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12072-011-9277-8","article-title":"Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network","volume":"6","author":"Vuppalanchi","year":"2012","journal-title":"Hepatol Int"},{"issue":"9","key":"10.1016\/j.cld.2015.10.011_bib10","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/01.mcg.0000139072.38580.a0","article-title":"Prevalence and significance of autoantibodies in patients with non-alcoholic steatohepatitis","volume":"38","author":"Cotler","year":"2004","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2015.10.011_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cld.2007.02.004","article-title":"Role of liver biopsy and serum markers of liver fibrosis in non-alcoholic fatty liver disease","volume":"11","author":"Adams","year":"2007","journal-title":"Clin Liver Dis"},{"issue":"4","key":"10.1016\/j.cld.2015.10.011_bib12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.cld.2009.07.008","article-title":"Histopathology of non-alcoholic fatty liver disease","volume":"13","author":"Brunt","year":"2009","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.cld.2015.10.011_bib13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.hepres.2005.09.016","article-title":"Histological study on comparison between NASH and ALD","volume":"33","author":"Nakano","year":"2005","journal-title":"Hepatol Res"},{"issue":"6","key":"10.1016\/j.cld.2015.10.011_bib14","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2015.10.011_bib15","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/hep.1840220616","article-title":"The natural history of nonalcoholic fatty liver: a follow-up study","volume":"22","author":"Teli","year":"1995","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2015.10.011_bib16","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/hep.26455","article-title":"Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials","volume":"58","author":"Noureddin","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2015.10.011_bib17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1148\/rg.291075123","article-title":"Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis","volume":"29","author":"Cassidy","year":"2009","journal-title":"Radiographics"},{"issue":"3","key":"10.1016\/j.cld.2015.10.011_bib18","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/hep.23784","article-title":"Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease","volume":"52","author":"Neuschwander-Tetri","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2015.10.011_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hep.21223","article-title":"In\u00a0vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease","volume":"44","author":"Wieckowska","year":"2006","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.cld.2015.10.011_bib20","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1111\/j.1572-0241.2000.03293.x","article-title":"An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities","volume":"95","author":"Sorbi","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2015.10.011_bib21","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2015.10.011_bib22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1055\/s-0034-1371083","article-title":"Hepatic pathology among patients without known liver disease undergoing bariatric surgery: observations and a perspective from the Longitudinal Assessment of Bariatric Surgery (LABS) study","volume":"34","author":"Kleiner","year":"2014","journal-title":"Semin Liver Dis"},{"issue":"1","key":"10.1016\/j.cld.2015.10.011_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0032-1306421","article-title":"Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research","volume":"32","author":"Kleiner","year":"2012","journal-title":"Semin Liver Dis"},{"issue":"5","key":"10.1016\/j.cld.2015.10.011_bib24","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2008.01.016","article-title":"Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease","volume":"48","author":"Chalasani","year":"2008","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2015.10.011_bib25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0168-8278(02)00073-9","article-title":"In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases","volume":"37","author":"Seki","year":"2002","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2015.10.011_bib26","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/hep.22724","article-title":"Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the Nonalcoholic Steatohepatitis Clinical Research Network","volume":"49","author":"Brunt","year":"2009","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2015.10.011_bib27","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/hep.26937","article-title":"The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease","volume":"59","author":"Gadd","year":"2014","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2015.10.011_bib28","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1572-0241.2006.00419.x","article-title":"Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery","volume":"101","author":"Barker","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2015.10.011_bib29","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/hep.20251","article-title":"Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss","volume":"39","author":"Dixon","year":"2004","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2015.10.011_bib30","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/hep.1840380427","article-title":"Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone","volume":"38","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2015.10.011_bib31","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.humpath.2011.07.007","article-title":"Costaining for keratins 8\/18 plus ubiquitin improves detection of hepatocyte injury in nonalcoholic fatty liver disease","volume":"43","author":"Guy","year":"2012","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.cld.2015.10.011_bib32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.humpath.2003.09.018","article-title":"Pathologic features associated with fibrosis in nonalcoholic fatty liver disease","volume":"35","author":"Gramlich","year":"2004","journal-title":"Hum Pathol"},{"issue":"10","key":"10.1016\/j.cld.2015.10.011_bib33","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.yexcr.2007.04.024","article-title":"From Mallory to Mallory-Denk bodies: what, how and why?","volume":"313","author":"Zatloukal","year":"2007","journal-title":"Exp Cell Res"},{"issue":"7","key":"10.1016\/j.cld.2015.10.011_bib34","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1053\/jlts.2001.25453","article-title":"Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease","volume":"7","author":"Charlton","year":"2001","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2015.10.011_bib35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00004836-199503000-00011","article-title":"Two cases from the spectrum of nonalcoholic steatohepatitis","volume":"20","author":"Abdelmalek","year":"1995","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2015.10.011_bib36","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/hep.1840110114","article-title":"The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years","volume":"11","author":"Powell","year":"1990","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2015.10.011_bib37","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/hep.510290347","article-title":"Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease","volume":"29","author":"Caldwell","year":"1999","journal-title":"Hepatology"},{"issue":"4 Pt 1","key":"10.1016\/j.cld.2015.10.011_bib38","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1053\/jhep.2000.17894","article-title":"Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study","volume":"32","author":"Poonawala","year":"2000","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2015.10.011_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0002-9343(99)00315-0","article-title":"Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds","volume":"108","author":"Struben","year":"2000","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.cld.2015.10.011_bib40","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0168-8278(99)80033-6","article-title":"Mitochondrial abnormalities in non-alcoholic steatohepatitis","volume":"31","author":"Caldwell","year":"1999","journal-title":"J\u00a0Hepatol"},{"issue":"13","key":"10.1016\/j.cld.2015.10.011_bib41","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.295.13.1549","article-title":"Prevalence of overweight and obesity in the United States, 1999-2004","volume":"295","author":"Ogden","year":"2006","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.cld.2015.10.011_bib42","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1053\/j.gastro.2008.08.050","article-title":"Clinical correlates of histopathology in\u00a0pediatric nonalcoholic steatohepatitis","volume":"135","author":"Patton","year":"2008","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2015.10.011_bib43","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/hep.23133","article-title":"Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study","volume":"50","author":"Carter-Kent","year":"2009","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.cld.2015.10.011_bib44","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2015.10.011_bib45","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2015.10.011_bib46","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/hep.25889","article-title":"Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients","volume":"56","author":"Bedossa","year":"2012","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2015.10.011_bib47","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/hep.27173","article-title":"Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease","volume":"60","author":"Bedossa","year":"2014","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2015.10.011_bib48","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1053\/jhep.2003.09022","article-title":"Sampling variability of liver fibrosis in chronic hepatitis C","volume":"38","author":"Bedossa","year":"2003","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2015.10.011_bib49","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1053\/jhep.2003.10010","article-title":"Liver biopsy size matters in chronic hepatitis: bigger is better","volume":"38","author":"Scheuer","year":"2003","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2015.10.011_bib50","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1309\/EY72F1EN9XCB1KXX","article-title":"Fibrosis heterogeneity in nonalcoholic steatohepatitis and hepatitis C virus needle core biopsy specimens","volume":"123","author":"Goldstein","year":"2005","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"10.1016\/j.cld.2015.10.011_bib51","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","article-title":"Sampling variability of liver biopsy in nonalcoholic fatty liver disease","volume":"128","author":"Ratziu","year":"2005","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2015.10.011_bib52","first-page":"560","article-title":"Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations","volume":"11","author":"Younossi","year":"1998","journal-title":"Mod Pathol"},{"issue":"15","key":"10.1016\/j.cld.2015.10.011_bib53","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJM197004092821502","article-title":"Effect on hepatic morphology of treatment of obesity by fasting, reducing diets and small-bowel bypass","volume":"282","author":"Drenick","year":"1970","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.cld.2015.10.011_bib54","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0016-5085(19)32939-7","article-title":"Editorial: steatosis-Mallory's hyaline-cirrhosis: can their relationships be resolved by an experiment of nature?","volume":"67","author":"Popper","year":"1974","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2015.10.011_bib55","first-page":"271","article-title":"Editorial: fatty liver-steatonecrosis-cirrhosis","volume":"22","author":"Thaler","year":"1975","journal-title":"Acta Hepatogastroenterol (Stuttg)"},{"issue":"2","key":"10.1016\/j.cld.2015.10.011_bib56","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jhep.2009.03.019","article-title":"Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis","volume":"51","author":"Argo","year":"2009","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2015.10.011_bib57","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2015.10.011_bib58","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jhep.2014.11.034","article-title":"Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management","volume":"62","author":"McPherson","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2015.10.011_bib59","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jhep.2013.04.027","article-title":"A\u00a0systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver","volume":"59","author":"Pais","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2015.10.011_bib60","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, associates with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2015.10.011_bib61","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/0046-8177(89)90249-9","article-title":"Nonalcoholic steatohepatitis: a study of 49 patients","volume":"20","author":"Lee","year":"1989","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1016\/j.cld.2015.10.011_bib62","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0016-5085(94)90235-6","article-title":"Nonalcoholic steatohepatitis: an expanded clinical entity","volume":"107","author":"Bacon","year":"1994","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2015.10.011_bib63","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0016-5085(00)70364-7","article-title":"Liver fibrosis in overweight patients","volume":"118","author":"Ratziu","year":"2000","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.cld.2015.10.011_bib64","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/jcp.55.9.689","article-title":"Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury?","volume":"55","author":"Evans","year":"2002","journal-title":"J\u00a0Clin Pathol"},{"issue":"9","key":"10.1016\/j.cld.2015.10.011_bib65","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1111\/j.1572-0241.2003.07659.x","article-title":"The natural history of nonalcoholic fatty liver disease: a clinical histopathological study","volume":"98","author":"Harrison","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2015.10.011_bib66","first-page":"820","article-title":"Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies","volume":"40","author":"Fassio","year":"2004","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2015.10.011_bib67","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jhep.2004.09.012","article-title":"The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies","volume":"42","author":"Adams","year":"2005","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2015.10.011_bib68","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2036.2005.02334.x","article-title":"Histological progression of non-alcoholic fatty liver disease in Chinese patients","volume":"21","author":"Hui","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.cld.2015.10.011_bib69","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2015.10.011_bib70","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1665-2681(19)31748-X","article-title":"NASH and cryptogenic cirrhosis: a histological analysis","volume":"8","author":"Caldwell","year":"2009","journal-title":"Ann Hepatol"},{"issue":"11","key":"10.1016\/j.cld.2015.10.011_bib71","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1136\/gut.2008.171280","article-title":"The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years","volume":"58","author":"Feldstein","year":"2009","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.cld.2015.10.011_bib72","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/ajg.2009.587","article-title":"Predicting fibrosis worsening in obese patients with NASH through parenchymal fibronectin, HOMA-IR, and hypertension","volume":"105","author":"Sorrentino","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.cld.2015.10.011_bib73","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1136\/gut.2009.205088","article-title":"Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years","volume":"59","author":"Wong","year":"2010","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.cld.2015.10.011_bib74","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2337\/dc09-0148","article-title":"Histological course of nonalcoholic fatty liver disease in Japanese patients: tight glycemic control, rather than weight reduction, ameliorates liver fibrosis","volume":"33","author":"Hamaguchi","year":"2010","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.cld.2015.10.011_bib75","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.gcb.2010.06.004","article-title":"Progression from isolated steatosis to steatohepatitis and fibrosis in nonalcoholic fatty liver disease","volume":"35","author":"Pais","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"11","key":"10.1016\/j.cld.2015.10.011_bib76","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1111\/j.1572-0241.2003.08699.x","article-title":"Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis","volume":"98","author":"Harrison","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2015.10.011_bib77","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/hep.20092","article-title":"Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial","volume":"39","author":"Lindor","year":"2004","journal-title":"Hepatology"},{"issue":"22","key":"10.1016\/j.cld.2015.10.011_bib78","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa060326","article-title":"A\u00a0placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis","volume":"355","author":"Belfort","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.cld.2015.10.011_bib79","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.cgh.2006.09.025","article-title":"Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis","volume":"4","author":"Dufour","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2015.10.011_bib80","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1053\/j.gastro.2008.06.047","article-title":"Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis","volume":"135","author":"Aithal","year":"2008","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2015.10.011_bib81","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.gastro.2008.03.078","article-title":"Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial","volume":"135","author":"Ratziu","year":"2008","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2015.10.011_bib82","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/hep.23239","article-title":"Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial","volume":"50","author":"Abdelmalek","year":"2009","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.cld.2015.10.011_bib83","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1080\/00365520902845268","article-title":"Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial","volume":"44","author":"Haukeland","year":"2009","journal-title":"Scand J Gastroenterol"},{"issue":"10","key":"10.1016\/j.cld.2015.10.011_bib84","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/MCG.0b013e31819c392e","article-title":"A\u00a0pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: a randomized placebo-controlled trial","volume":"43","author":"Nelson","year":"2009","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2015.10.011_bib85","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hep.23727","article-title":"High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial","volume":"52","author":"Leuschner","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2015.10.011_bib86","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.23276","article-title":"Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis","volume":"51","author":"Promrat","year":"2010","journal-title":"Hepatology"},{"issue":"18","key":"10.1016\/j.cld.2015.10.011_bib87","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.cld.2015.10.011_bib88","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/jama.2011.520","article-title":"Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial","volume":"305","author":"Lavine","year":"2011","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.cld.2015.10.011_bib89","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1665-2681(19)31539-X","article-title":"Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial","volume":"10","author":"Van Wagner","year":"2011","journal-title":"Ann Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2015.10.011_bib90","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/hep.24544","article-title":"Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial","volume":"54","author":"Zein","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2015.10.011_bib91","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1440-1746.2012.07286.x","article-title":"Treatment of non-alcoholic steatohepatitis with Phyllanthus urinaria: a randomized trial","volume":"28","author":"Wong","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2015.10.011_bib92","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/j.gastro.2014.04.046","article-title":"No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial","volume":"147","author":"Sanyal","year":"2014","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2015.10.011_bib93","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s00125-013-3149-9","article-title":"The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial","volume":"57","author":"Takeshita","year":"2014","journal-title":"Diabetologia"},{"issue":"9972","key":"10.1016\/j.cld.2015.10.011_bib94","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326115001129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326115001129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T20:17:08Z","timestamp":1567455428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326115001129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":94,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S1089326115001129"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2015.10.011","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2015.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}